The Efficacy of Sclerotherapy for Conservative Treatment of Ovarian Pseudocyst

난소의 가성 낭종의 보존적 치료로서 경화술의 효용성

  • Ahn, Sung-Hee (Department of Obstetrics and Gynecology, Ajou University School of Medicine) ;
  • Yoo, Seung-Chul (Department of Obstetrics and Gynecology, Ajou University School of Medicine) ;
  • Jo, Mi-Yeong (Department of Obstetrics and Gynecology, Ajou University School of Medicine) ;
  • Kim, Mi-Ran (Department of Obstetrics and Gynecology, Ajou University School of Medicine) ;
  • Hwang, Kyung-Joo (Department of Obstetrics and Gynecology, Ajou University School of Medicine) ;
  • Ryu, Hee-Suk (Department of Obstetrics and Gynecology, Ajou University School of Medicine)
  • 안성희 (아주대학교 의과대학 산부인과학교실) ;
  • 유승철 (아주대학교 의과대학 산부인과학교실) ;
  • 조미영 (아주대학교 의과대학 산부인과학교실) ;
  • 김미란 (아주대학교 의과대학 산부인과학교실) ;
  • 황경주 (아주대학교 의과대학 산부인과학교실) ;
  • 유희석 (아주대학교 의과대학 산부인과학교실)
  • Published : 2002.12.30

Abstract

Objective: To evaluate the efficacy of sclerotherapy for conservative treatment of ovarian pseudocyst. Methods: Patients with ovarian pseudocyst who had undergone sclerotherapy at Ajou University Hospital from February, 1997 to March, 2002 were included in this study. Sclerotherapy was performed as follows: Under intravenous analgesia, the cyst was irrigated with dehydrated alcohol after aspiration under transvaginal sonography. The aspirated contents and alcohol irrigated contents were sent for cytologic examination. Results: 71 patients with ovarian pseudocyst were performed sclerotherapy. All but 2 patients were followed up for 0.5 to 33 months with transvaginal sonography and pelvic examination. Mean age of the patients was 40 years old. Mean size of the pseudocyst was 8.0 cm, mean amount of aspiration fluid was 179.8 ml, and average follow-up duration was 6.0 months. All had abdominal or pelvic surgical history and 38 patients (58.9%) of them had undergone hysterectomy. 44 of 71 patients (62.0%) were performed sclerotherapy only one time. 27 patients (38.0%) recurred and were undergone more than one time. Complication was not occurred in all cases. Conclusions: We concluded that although pseudocyst after sclerotherapy has high recurrence rate, sclerotherapy was an safe and effective method for conservative treatment of ovarian pseudocyst.

Keywords

References

  1. Sohaey R, Gardner TL, Woodward PJ, Peterson CM. Sonographic diagnosis of peritoneal inclusion cyst. J Ultrasound Med 1995; 14: 913-7 https://doi.org/10.7863/jum.1995.14.12.913
  2. Kim JS, Lee HJ, Woo SK, Lee TS. Peritoneal inclusion cysts and their relationship to the ovaries: Evaluation with sonography. Radiology 1997; 204: 481-4 https://doi.org/10.1148/radiology.204.2.9240539
  3. Gussman D, Thickman D, Wheeler JE. Postoperative peritoneal cysts. Obstet Gynecol 1986; 68(3 Suppl): S53-5
  4. Bret PM, Atri M, Guibaud L, Gillett P, Seymour RJ, Senterman MK. Ovarian cysts in postmenopausal women: Preliminary results with transvaginal alcohol sclerosis. Radiology 1992; 184: 661-3 https://doi.org/10.1148/radiology.184.3.1509048
  5. AbdRabbo S, Atta A. Aspiration and tetracycline sclerotherapy: a novel method for management of vaginal and vulval Gartner cysts. Int J Gynecol Obstet 1991; 35: 235-7 https://doi.org/10.1016/0020-7292(91)90292-D
  6. Koninckx PR, Penaer M, Brosens IA. Origin of peritoneal fluid in women: an ovarian exudate product. Br J Obstet Gynecol 1980; 87: 177-83 https://doi.org/10.1111/j.1471-0528.1980.tb04514.x
  7. Hoffer FA, Kozakewich H, Colodny A, Goldstein DP. Peritoneal inclusion cysts: ovarian fluid in peritoneal adhesions. Radiology 1988; 169: 189-91 https://doi.org/10.1148/radiology.169.1.3047785
  8. Jeong JY, Kim SH. Sclerotherapy of peritoneal inclusion cysts: Preliminary results in seven patients. Korean J Radiol 2001; 2: 164-70 https://doi.org/10.3348/kjr.2001.2.3.164
  9. Lipitz S, Seidman DS, Schiff E, Achiron R, Menczer J. Treatment of pelvic peritoneal cysts by drainage and ethanol instillation. Obstet Gynecol 1995; 86: 297-9 https://doi.org/10.1016/0029-7844(95)00157-M
  10. Zanetta G, Diego T, Lissoni A, Pittelli M, Valle CD, Rangoni G. Ultrasound-guided aspiration of endometriomas: possible applications and limitations. Fertil Steril 1995; 64: 709-12 https://doi.org/10.1016/S0015-0282(16)57843-1
  11. 이희춘, 유정현, 황경주, 권혁찬, 장기흥, 유희석, 등 재발된 양성 자궁부속기 낭종의 치료에 있어서 경화치료술의 효용성. 대한산부회지 1998; 41: 1055-60
  12. Chang CC, Lee HF, Tsai HD, Lo HY. Sclerotherapy an adjuvant therapy to emdometriosis. Int J Gynecol Obstet 1997; 59: 31-4 https://doi.org/10.1016/S0020-7292(97)00122-7
  13. Rubinson RM, Bolooki H. Intrapleural tetracycline for control of malignant pleural effusion: a preliminary report. South Med J 1972; 65: 847-9 https://doi.org/10.1097/00007611-197207000-00016
  14. Bean WJ. Renal cysts: treatment with alcohol. Radiology 1981; 138: 329-31 https://doi.org/10.1148/radiology.138.2.7455112
  15. Simonetti G, Profili S, Sergiacomi GL, Meloni GB, Orlacchio A. Percutaneous treatment of hepatic cysts by aspiration and sclerotherapy. Cardiovasc Interven Radiol 1993; 16: 81-4 https://doi.org/10.1007/BF02602983
  16. Zingrillo M, Ghiggi MR, Liuzzi A. A large, nonfunctioning parathyroid cyst recurring after aspiraton and subsequently cured by percutaneous ethanol injection. J Clin Ultrasound 1996; 24: 378-82 https://doi.org/10.1002/(SICI)1097-0096(199609)24:7<378::AID-JCU10>3.0.CO;2-D
  17. Lohela P. Ultrasound-guided drainges and sclerotherapy. Eur Radiol 2002; 12: 288-95 https://doi.org/10.1007/s00330-001-1252-7
  18. Gelczer RK, Charboneau JW, Hussain S, Brown DL. Complications of percutaneous ethanol ablation. J Ultrasound Med 1998; 17:531-3 https://doi.org/10.7863/jum.1998.17.8.531
  19. Noma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynecol Obstet 2001;72: 35-9 https://doi.org/10.1016/S0020-7292(00)00307-6
  20. Okagaki R, Osuga Y, Momoeda M, Tsutsumi O, Taketani Y. Laparoscopic findings after ultrasound-guided transvaginal ethanol sclerotherapy for ovarian endometrial cyst. Human reproduction 1999; 14:270 https://doi.org/10.1093/humrep/14.1.270